Basic Information
SaponiQx is a cutting-edge biopharmaceutical company with a vision to protect the health of people worldwide. We aim to develop safe and effective vaccines by expanding the use of saponin adjuvants. SaponiQx, a subsidiary of Agenus Inc., owns the proprietary adjuvant STIMULON QS-21, a key component of the AS01 adjuvant used in several leading vaccines.
SaponiQx
Massachusetts,United States of America
15~50 people
January 01, 2021
--
Enterprise Profile
Industrial Sector
Technology
Application Scenarios